Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Business Update
Hair removal company launches dermatology division to target gene technology
January 6th, 2005
Sirna Therapeutics, Inc. (RNAI) announced the first program to apply RNA interference (RNAi) technology to dermatology, with an initial focus on hair removal, an estimated $4 billion market in the United States. Sirna Dermatology has targeted a critical gene essential for hair growth and has demonstrated that reduction of this gene's expression by a topically administered chemically modified siRNA permanently disrupts hair follicle integrity in an animal model. The company anticipates initiating human trials in 2006. Sirna, in the formation of its dermatology division, has acquired Skinetics Biosciences, Inc. Sirna and Skinetics Biosciences have...
Source: Women's Health Weekly (2005-01-06)
|
